CIM
IOVA icon

CIM Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History

CIM Investment Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,423
Closed -$80.3K – 258
2025
Q4 		$80.3K Hold
29,423
– – 0.02% 238
2025
Q3 		$63.8K Sell
29,423
-31,694
-52% -$74.8K 0.02% 243
2025
Q2 		$282K Buy
61,117
+30,671
+101% +$76.3K 0.05% 217
2025
Q1 		$101K Sell
30,446
-726
-2% -$3.74K 0.02% 230
2024
Q4 		$231K Hold
31,172
– – 0.07% 214
2024
Q3 		$293K Hold
31,172
– – 0.09% 190
2024
Q2 		$250K Buy
31,172
+17,399
+126% +$186K 0.08% 200
2024
Q1 		$204K Hold
13,773
– – 0.06% 255
2023
Q4 		$112K Hold
13,773
– – 0.04% 277
2023
Q3 		$62.7K Hold
13,773
– – 0.02% 273
2023
Q2 		$97K Hold
13,773
– – 0.03% 269
2023
Q1 		$84.2K Buy
13,773
+476
+4% +$3.28K 0.03% 257
2022
Q4 		$85K Buy
+13,297
New +$104K 0.03% 237

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return